Utah Medical Products Stock Price History
UTMD Stock | USD 61.25 0.06 0.1% |
Below is the normalized historical share price chart for Utah Medical Products extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Utah Medical stands at 61.25, as last reported on the 30th of January, with the highest price reaching 61.91 and the lowest price hitting 61.22 during the day.
If you're considering investing in Utah Stock, it is important to understand the factors that can impact its price. Utah Medical Products owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.053, which indicates the firm had a -0.053 % return per unit of risk over the last 3 months. Utah Medical Products exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Utah Medical's Risk Adjusted Performance of (0.05), coefficient of variation of (1,578), and Variance of 1.27 to confirm the risk estimate we provide.
At present, Utah Medical's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 163.6 M, whereas Common Stock Total Equity is forecasted to decline to about 32 K. . At present, Utah Medical's Price Earnings To Growth Ratio is projected to increase based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 16.69, whereas Price Earnings Ratio is forecasted to decline to 14.23. Utah Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 1999 | 200 Day MA 66.2906 | 50 Day MA 63.055 | Beta 0.08 |
Utah |
Sharpe Ratio = -0.053
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | UTMD |
Estimated Market Risk
1.16 actual daily | 10 90% of assets are more volatile |
Expected Return
-0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Utah Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Utah Medical by adding Utah Medical to a well-diversified portfolio.
Price Book 1.6918 | Enterprise Value Ebitda 6.8657 | Price Sales 4.7176 | Shares Float 3 M | Earnings Share 4.28 |
Utah Medical Stock Price History Chart
There are several ways to analyze Utah Stock price data. The simplest method is using a basic Utah candlestick price chart, which shows Utah Medical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 11, 2024 | 68.19 |
Lowest Price | January 7, 2025 | 60.67 |
Utah Medical January 30, 2025 Stock Price Synopsis
Various analyses of Utah Medical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Utah Stock. It can be used to describe the percentage change in the price of Utah Medical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Utah Stock.Utah Medical Accumulation Distribution | 210.92 | |
Utah Medical Price Rate Of Daily Change | 1.00 | |
Utah Medical Price Daily Balance Of Power | (0.09) | |
Utah Medical Price Action Indicator | (0.34) |
Utah Medical January 30, 2025 Stock Price Analysis
Utah Stock Price History Data
The price series of Utah Medical for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 has a statistical range of 7.52 with a coefficient of variation of 2.95. The daily prices for the period are distributed with arithmetic mean of 63.47. The median price for the last 90 days is 63.43. The company experienced 3:2 stock split on 22nd of March 1993. Utah Medical Products paid out dividends to its shareholders on 2024-12-16.Open | High | Low | Close | Volume | ||
01/30/2025 | 61.31 | 61.91 | 61.22 | 61.25 | 18,925 | |
01/29/2025 | 62.57 | 62.57 | 61.19 | 61.31 | 18,277 | |
01/28/2025 | 63.80 | 65.56 | 62.90 | 63.00 | 31,837 | |
01/27/2025 | 62.72 | 65.19 | 62.51 | 64.17 | 20,582 | |
01/24/2025 | 62.65 | 62.92 | 61.95 | 62.92 | 37,399 | |
01/23/2025 | 62.62 | 63.26 | 62.23 | 62.75 | 13,033 | |
01/22/2025 | 62.53 | 63.32 | 62.50 | 62.83 | 16,528 | |
01/21/2025 | 62.20 | 62.90 | 62.00 | 62.78 | 29,328 | |
01/17/2025 | 62.00 | 62.37 | 61.62 | 62.16 | 15,702 | |
01/16/2025 | 62.38 | 62.95 | 61.71 | 61.99 | 31,314 | |
01/15/2025 | 62.56 | 63.25 | 61.39 | 62.87 | 22,662 | |
01/14/2025 | 60.93 | 61.89 | 60.93 | 61.49 | 19,171 | |
01/13/2025 | 60.49 | 61.80 | 60.08 | 61.02 | 24,022 | |
01/10/2025 | 60.73 | 61.29 | 60.17 | 60.91 | 29,472 | |
01/08/2025 | 60.56 | 61.14 | 60.50 | 60.92 | 13,061 | |
01/07/2025 | 60.76 | 61.00 | 60.51 | 60.67 | 19,141 | |
01/06/2025 | 61.30 | 61.63 | 60.64 | 60.89 | 14,229 | |
01/03/2025 | 61.35 | 61.72 | 60.76 | 61.35 | 15,501 | |
01/02/2025 | 61.44 | 62.53 | 61.21 | 61.35 | 14,666 | |
12/31/2024 | 60.83 | 61.58 | 60.76 | 61.47 | 15,310 | |
12/30/2024 | 61.85 | 61.85 | 60.84 | 60.90 | 19,240 | |
12/27/2024 | 62.03 | 62.25 | 61.30 | 61.89 | 14,645 | |
12/26/2024 | 61.72 | 62.31 | 61.53 | 61.58 | 16,235 | |
12/24/2024 | 61.47 | 61.66 | 60.82 | 61.43 | 6,357 | |
12/23/2024 | 61.24 | 61.90 | 60.39 | 61.13 | 28,620 | |
12/20/2024 | 61.66 | 62.94 | 60.74 | 61.02 | 50,638 | |
12/19/2024 | 62.40 | 62.61 | 61.67 | 62.08 | 28,791 | |
12/18/2024 | 62.75 | 63.32 | 61.48 | 62.00 | 35,920 | |
12/17/2024 | 62.75 | 63.04 | 62.50 | 62.53 | 33,700 | |
12/16/2024 | 62.75 | 63.41 | 62.62 | 62.95 | 25,894 | |
12/13/2024 | 63.60 | 63.60 | 62.56 | 62.61 | 13,842 | |
12/12/2024 | 63.44 | 64.30 | 62.96 | 63.34 | 14,087 | |
12/11/2024 | 63.34 | 64.39 | 62.98 | 63.64 | 18,511 | |
12/10/2024 | 63.61 | 64.21 | 63.19 | 63.38 | 17,079 | |
12/09/2024 | 63.30 | 64.13 | 62.69 | 63.31 | 18,194 | |
12/06/2024 | 63.44 | 63.78 | 62.71 | 63.53 | 17,588 | |
12/05/2024 | 63.57 | 63.64 | 63.08 | 63.43 | 18,262 | |
12/04/2024 | 63.89 | 64.04 | 63.58 | 63.96 | 14,229 | |
12/03/2024 | 64.68 | 65.07 | 64.03 | 64.09 | 10,794 | |
12/02/2024 | 64.36 | 65.24 | 64.36 | 65.07 | 13,583 | |
11/29/2024 | 64.51 | 65.14 | 64.51 | 64.93 | 8,745 | |
11/27/2024 | 65.59 | 65.59 | 64.64 | 64.83 | 10,601 | |
11/26/2024 | 64.83 | 65.08 | 64.36 | 64.85 | 17,482 | |
11/25/2024 | 65.03 | 66.83 | 65.03 | 65.65 | 24,761 | |
11/22/2024 | 63.80 | 65.47 | 63.80 | 64.97 | 21,989 | |
11/21/2024 | 63.89 | 64.26 | 63.65 | 64.26 | 18,620 | |
11/20/2024 | 63.34 | 64.02 | 63.34 | 63.87 | 11,682 | |
11/19/2024 | 65.26 | 65.50 | 64.29 | 64.38 | 25,476 | |
11/18/2024 | 65.42 | 66.29 | 65.03 | 65.77 | 21,755 | |
11/15/2024 | 66.46 | 67.27 | 65.21 | 65.73 | 26,890 | |
11/14/2024 | 66.98 | 66.98 | 65.59 | 66.20 | 25,290 | |
11/13/2024 | 67.91 | 67.91 | 66.62 | 66.64 | 18,572 | |
11/12/2024 | 68.33 | 68.66 | 67.83 | 68.02 | 19,274 | |
11/11/2024 | 68.02 | 68.43 | 66.93 | 68.19 | 13,533 | |
11/08/2024 | 67.04 | 68.24 | 67.04 | 67.58 | 21,051 | |
11/07/2024 | 66.68 | 68.20 | 66.47 | 66.90 | 15,983 | |
11/06/2024 | 65.46 | 67.76 | 65.46 | 66.84 | 74,734 | |
11/05/2024 | 64.59 | 65.25 | 63.64 | 63.69 | 63,411 | |
11/04/2024 | 63.56 | 64.38 | 63.56 | 64.33 | 25,969 | |
11/01/2024 | 63.55 | 63.78 | 63.27 | 63.78 | 18,079 | |
10/31/2024 | 63.75 | 63.82 | 63.07 | 63.07 | 27,170 |
About Utah Medical Stock history
Utah Medical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Utah is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Utah Medical Products will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Utah Medical stock prices may prove useful in developing a viable investing in Utah Medical
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 3.3 M | 5 M | |
Net Income Applicable To Common Shares | 18.9 M | 11.8 M |
Utah Medical Quarterly Net Working Capital |
|
Utah Medical Stock Technical Analysis
Utah Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Utah Medical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Utah Medical's price direction in advance. Along with the technical and fundamental analysis of Utah Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Utah to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.1) | |||
Total Risk Alpha | (0.18) | |||
Treynor Ratio | (0.43) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |